<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9809671</journal-id>
<journal-id journal-id-type="pubmed-jr-id">21092</journal-id>
<journal-id journal-id-type="nlm-ta">Nat Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Nature neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1097-6256</issn>
<issn pub-type="epub">1546-1726</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27694994</article-id>
<article-id pub-id-type="pmc">5104192</article-id>
<article-id pub-id-type="doi">10.1038/nn.4402</article-id>
<article-id pub-id-type="manuscript">NIHMS815183</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Genovese</surname>
<given-names>Giulio</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fromer</surname>
<given-names>Menachem</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stahl</surname>
<given-names>Eli A.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ruderfer</surname>
<given-names>Douglas M.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chambert</surname>
<given-names>Kimberly</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Landén</surname>
<given-names>Mikael</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moran</surname>
<given-names>Jennifer L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Purcell</surname>
<given-names>Shaun M.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sklar</surname>
<given-names>Pamela</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sullivan</surname>
<given-names>Patrick F.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hultman</surname>
<given-names>Christina M.</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McCarroll</surname>
<given-names>Steven A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA</aff>
<aff id="A2"><label>2</label>Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA</aff>
<aff id="A3"><label>3</label>Department of Genetics, Harvard Medical School, Boston, MA 02115, USA</aff>
<aff id="A4"><label>4</label>Division of Psychiatric Genomics, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA</aff>
<aff id="A5"><label>5</label>Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA</aff>
<aff id="A6"><label>6</label>Department of Psychiatry and Neurochemistry, Institute of Neuroscience a Physiology at Sahlgrenska Academy at University of Gothenburg, 413 45 Göteborg, Sweden</aff>
<aff id="A7"><label>7</label>Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill, North Carolina 27599-7264, USA</aff>
<aff id="A8"><label>8</label>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm SE-171 77, Sweden</aff>
<author-notes>
<corresp id="CR1">Correspondence should be addressed to S.A.M. (<email>mccarroll@genetics.med.harvard.edu</email>)</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>9</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>03</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>03</day>
<month>4</month>
<year>2017</year>
</pub-date>
<volume>19</volume>
<issue>11</issue>
<fpage>1433</fpage>
<lpage>1441</lpage>
<!--elocation-id from pubmed: 10.1038/nn.4402-->
<permissions>
<license>
<license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<uri xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms" xlink:type="simple">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p>
</license>
</permissions>
<abstract>
<p id="P1">By analyzing the exomes of 12,332 unrelated Swedish individuals – including 4,877 affected with schizophrenia – in ways informed by exome sequences from 45,376 other individuals, we identified 244,246 coding-sequence and splice-site ultra-rare variants (URVs) that were unique to individual Swedes. We found that gene-disruptive and putatively protein-damaging URVs (but not synonymous URVs) were more abundant in schizophrenia cases than controls (<italic>P</italic> = 1.3 × 10<sup>−10</sup>). This elevation of protein-compromising URVs was several times larger than an analogously elevated rate for <italic>de novo</italic> mutations, suggesting that most rare-variant effects on schizophrenia risk are inherited. Among individuals with schizophrenia, the elevated frequency of protein-compromising URVs was concentrated in brain-expressed genes, particularly in neuronally expressed genes; most of this genetic signal arose from large sets of genes whose RNAs have been found to interact with synaptically localized proteins. Our results suggest that synaptic dysfunction may mediate a large fraction of strong, individually rare genetic influences on schizophrenia risk.</p>
</abstract>
</article-meta>
</front>
<body>
<p id="P2">Schizophrenia is a psychiatric disorder with a lifetime risk of about 0.7%<sup><xref ref-type="bibr" rid="R1">1</xref></sup> and a heritability of 60–80%<sup><xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R3">3</xref></sup> despite greatly reduced reproductive fecundity<sup><xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R5">5</xref></sup>. Because individuals affected with schizophrenia have fewer offspring, purifying selection is expected to prevent high-risk alleles from reaching even modest allele frequencies<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. Indeed, estimates of selection (when based only on the reproductive costs of schizophrenia) may underestimate the actual selective pressure against such alleles given emerging evidence that such alleles have multiple adverse effects: for example, rare copy number variations (CNVs), implicated with penetrances ranging from 2–30% (the latter observed for 22q11.2 deletions), negatively impact cognition and fecundity even in their more-typical presentation without schizophrenia<sup><xref ref-type="bibr" rid="R7">7</xref></sup>. To the extent that such observations condition expectations for rare single-nucleotide variants, variants with a large effect on schizophrenia risk are likely to be rare in populations, requiring sequencing to find them.</p>
<p id="P3">Distinguishing those variants that are extremely rare from variants that are segregating in a population is ideally informed by sequencing very-large numbers of individuals from the same population. We thus analyzed the sequences of 12,332 unrelated individuals (4,946 affected with schizophrenia, 6,242 unaffected controls, and 1,144 with other psychiatric illnesses whose analysis is beyond the scope of the current study) from Sweden (<bold>Online Methods</bold>). We further informed this analysis with a much larger set of exome sequencing data from 45,376 individuals from multiple non-psychiatric cohorts ascertained by the Exome Aggregation Consortium<sup><xref ref-type="bibr" rid="R8">8</xref></sup>. This made it possible to identify among the Swedish research participants 244,246 coding-sequence and splice-site ultra-rare variants (URVs) that were present in single individuals – a set of variants that is greatly enriched for recent mutations, relative to the vastly larger fraction of heterozygosity that is due to less-rare variants (<bold><xref ref-type="fig" rid="F1">Fig. 1a</xref></bold>). This large set of variants made it possible to identify broad biological patterns among an excess of more than 1,000 protein-damaging URVs that we found in the exomes of 4,946 individuals affected with schizophrenia.</p>
<sec id="S1" sec-type="results">
<title>RESULTS</title>
<sec id="S2">
<title>Exome-wide enrichment of ultra-rare variants</title>
<p id="P4">We analyzed the protein-coding sequences (the exomes) of 12,332 unrelated Swedish individuals, including 4,946 affected with schizophrenia (2,951 males and 1,995 females), 6,242 unaffected controls (3,182 males and 3,060 females), and 1,144 affected with other disorders (443 males and 701 females, used for population genetic analyses but not as cases or controls). After removing 119 individuals for quality control reasons (mostly due to divergent ancestry, <bold>Online Methods</bold>), we identified 244,246 coding-sequence and splice-site URVs (among 4,877 schizophrenia cases and 6,203 controls) that were present in only one of the 12,332 unrelated Swedish exomes analyzed and never seen in the Exome Aggregation Consortium (ExAC) cohort (which numbered 45,376 individuals after excluding the subjects from this cohort and other subjects ascertained for psychiatric disorders).</p>
<p id="P5">We focused on URVs in most analyses because such variants – although comprising a tiny fraction (less than 0.2%) of the heterozygous sites in an individual – will be greatly enriched for recent mutations and thus have been exposed to fewer generations of purifying selection. The size of the Swedish cohort analyzed, and the additional sequence data for the Exome Aggregation Consortium, allowed us to greatly refine the identification of URVs; for example, among 5,092 (of the 12,332) individuals who were also part of an earlier sequencing study<sup><xref ref-type="bibr" rid="R9">9</xref></sup>, the additional data allowed us to re-classify ~66% of variants that had been “singletons” as segregating variants (not URVs in the current analysis). This may have been particularly helpful for refining analyses of challenging-to-interpret missense variants, as we describe below.</p>
<p id="P6">We classified coding-sequence and splice-site variants into four groups (<bold><xref ref-type="fig" rid="F1">Fig. 1b</xref></bold>):</p>
<list id="L1" list-type="bullet">
<list-item>
<p id="P7"><italic>synonymous</italic>: exonic variants not predicted to change the encoded protein (63,230 URVs);</p>
</list-item>
<list-item>
<p id="P8"><italic>missense non-damaging</italic>: missense variants not predicted to damage protein function (by the criteria below) (134,100 URVs);</p>
</list-item>
<list-item>
<p id="P9"><italic>damaging</italic>: missense variants predicted to compromise protein function per an algorithm (<bold>Online Methods</bold>), in-frame indels, or variants affecting protein-protein-contact domains (27,390 URVs); and</p>
</list-item>
<list-item>
<p id="P10"><italic>disruptive</italic>: variants that truncate or abrogate the encoded protein in a way that is readily classified as loss-of-function<sup><xref ref-type="bibr" rid="R10">10</xref></sup> or as triggering nonsense mediated decay (NMD)<sup><xref ref-type="bibr" rid="R11">11</xref></sup>. These included nonsense, frameshift, splice-site, and very rarely, read-through variants. (19,526 URVs).</p>
</list-item>
</list>
<p id="P11">The terms protein-“damaging” and gene-“disruptive” refer to predicted effects on individual gene copies and the encoded proteins, rather than effects on phenotypes; effects on phenotypes can be inferred only from association analysis.</p>
<p id="P12">Missense damaging URVs accounted for approximately 15% of all missense URVs (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 1</xref></bold>). There was a median of 2 disruptive and 2 damaging URVs per individual (4 total) (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 2</xref></bold>).</p>
<p id="P13">To assess whether schizophrenia was associated with an increased number of coding-sequence and splice-site URVs (in specific genes, across the exome, or in sets of genes), we used a linear regression model to control for possible confounding variables, including each individual’s overall number of detected URVs (including non-coding URVs), sex, birth year, the hybrid selection kit used for exome enrichment, and the first 20 principal components estimated from exome-wide SNP and indel genotypes (<bold><xref ref-type="supplementary-material" rid="SD7">Supplementary Table 1</xref></bold>).</p>
<p id="P14">An important negative control – to address the possibility that analyses could be affected by population structure, differences in average relatedness within the case and control groups, or by technical variation – is to ask whether functionally neutral forms of variation show any apparent differences in frequency between case and control groups. We did not observe a significant difference in the rate of synonymous URVs between schizophrenia cases and controls (<bold><xref ref-type="fig" rid="F1">Fig. 1c</xref></bold>). We also did not observe a significant difference for non-coding URVs (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 3a</xref></bold>).</p>
<p id="P15">In contrast, we observed significant case-control differences in the rates of disruptive URVs (a difference of 0.12 variants/person; 95% confidence interval [CI]=0.07–0.17; <italic>P</italic> = 1.8 × 10<sup>−6</sup>) and damaging URVs (0.12 variants/person; 95% CI=0.07–0.18; <italic>P</italic> = 3.4 × 10<sup>−5</sup>). (<italic>P</italic> values determined by permuting the phenotype data 10 million times agreed with <italic>P</italic> values from the linear regression analysis, and were: <italic>P</italic> = 0.81 for synonymous, <italic>P</italic> = 0.045 for missense non-damaging, <italic>P</italic> = 3.5 × 10<sup>−5</sup> for damaging, and <italic>P</italic> = 1.8 × 10<sup>−6</sup> for disruptive; this suggests that the <italic>P</italic> values from the regression model are well-calibrated) Damaging and disruptive URVs showed similarly elevated frequencies in cases and were thus combined into a single category termed dURVs (disruptive and damaging ultra-rare variants) for subsequent analyses.</p>
<p id="P16">Adjusting for covariates, there were 7% more dURVs in affected individuals than in controls (odds ratios [OR]=1.07; 95% CI=1.05-1.09; <italic>P</italic> = 1.5 × 10<sup>−10</sup>), as the case-associated elevation in dURVs (of about 0.25 variants/patient; 95% CI=0.17-0.32) occurred on a background of about 4 dURVs per patient. The elevated frequency of dURVs among individuals affected with schizophrenia appeared to arise from multiple types of dURVs, including in-frame indels, protein-protein-contact, splice-acceptor, splice-donor, stop-gained, and frame-shift variants (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 3b</xref></bold>).</p>
<p id="P17">To assure that this result was not the result of population stratification within Sweden, we further estimated the enrichment in a more genetically homogeneous subset of the Swedish cohort (3,554 schizophrenia cases and 5,164 controls) that excluded individuals with significant amounts of Finnish or Northern Sweden ancestry. Individuals with schizophrenia showed a similar dURV excess in this more genetically homogeneous group (excess of 0.25 dURVs/case, 95% CI 0.16-0.34; <italic>P</italic> = 2.2 × 10<sup>−8</sup>).</p>
<p id="P18">We next estimated the extent to which dURVs tend to be inherited or <italic>de novo</italic>. While parental DNA would be necessary to directly ascertain which specific dURVs are <italic>de novo</italic> mutations (DNMs), we can compare the schizophrenia-associated <italic>elevation</italic> in dURVs (~0.25 per exome) to an analogous elevation in DNMs detected in earlier studies of 617 affected and 1911 unaffected father-mother-offspring trios<sup><xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R13">13</xref></sup>. Using data from the trios, we estimated the frequencies of DNMs that were protein-damaging or -disruptive (dDNMs) by the same criteria we used to identify dURVs (including restricting to variants not previously observed in ExAC<sup><xref ref-type="bibr" rid="R8">8</xref></sup>). These data yielded an elevation of about 0.03 such DNMs per exome, based on the difference between rates of 0.185 (95% CI 0.151-0.219) for individuals with schizophrenia<sup><xref ref-type="bibr" rid="R12">12</xref></sup> and 0.156 (95% CI 0.139-0.174) for unaffected individuals<sup><xref ref-type="bibr" rid="R13">13</xref></sup>. This estimate (0.03 per exome) was several times smaller than the elevation of dURVs in affected individuals in our population-based study (0.25 per exome). (We note that such a comparison requires the imperfect assumption of uniform technical ascertainment across the sequencing studies; even under plausible relaxations of this assumption, the dURV excess greatly exceeds the dDNM excess. Also, when estimated by this same approach, rates of synonymous and non-damaging DNMs were similar – 0.475 in affected and 0.459 in unaffected individuals – suggesting that the analysis is well-calibrated.) We conclude that the great majority of the dURVs driving the elevated rates in schizophrenia were inherited rather than <italic>de novo</italic>, though the very-low allele frequency of these variants suggests that they are on average just a few generations old.</p>
<p id="P19">Although the elevated frequency of dURVs among affected individuals was statistically significant (<italic>P</italic> = 1.4 × 10<sup>−10</sup>), it was still only a modest increase of 0.25 dURVs on a background of about 4 dURVs per individual. This excess could in principle be concentrated in individual genes or in sets of functionally related genes, possibilities we address below.</p>
</sec>
<sec id="S3">
<title>Single gene burden analysis</title>
<p id="P20">Joint analysis of many rare variants that affect the same gene or sets of genes can increase power to identify genes whose disruption increases the risk of schizophrenia. To find individual genes that had significantly more rare variants in cases or controls, we performed a burden test using SKAT<sup><xref ref-type="bibr" rid="R14">14</xref></sup> adjusting for previously defined covariates (<bold>Online Methods</bold>). We tested for (a) disruptive, (b) damaging, (c) disruptive and damaging, and (d) missense variants that were either (i) ultra-rare, (ii) singletons in the Sweden cohort, (iii) had a minor allele count ≤5 (minor allele frequency &lt;0.02%), (iv) had a minor allele count ≤10 (minor allele frequency &lt;0.05%), (v) had a minor allele frequency &lt;0.1%, or (vi) had a minor allele frequency &lt;0.5%.</p>
<p id="P21">Given the sample size, our analysis would have &gt;90% power (at α = 2.5 × 10<sup>−6</sup>) to detect any gene for which rare, disruptive and damaging variants were present in 1% of schizophrenia cases, even if such variants had only a relatively modest effect size<sup><xref ref-type="bibr" rid="R15">15</xref></sup> (odds ratio of at least 3, i.e. about 2% penetrance), and still greater power if effect sizes were larger. No individual gene surpassed exome-wide significance in this analysis (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 4</xref></bold>), suggesting that no one gene is likely to have rare variants that explain even 1% of schizophrenia cases. The individual gene with the strongest enrichment was <italic>KL</italic> (<italic>klotho</italic>) (<bold><xref ref-type="supplementary-material" rid="SD7">Supplementary Table 2</xref></bold>), in which we found eight different dURVs in cases and none in controls (<italic>P</italic> = 3.7 × 10<sup>−4</sup>), but this result was not significant given the number of genes tested. Other models, based on higher levels of polygenicity, therefore appear to be more plausible: in a model in which a hypothetical gene is affected in 0.1% of schizophrenia cases, we would have only ~4% power to conclusively find this effect at exome-wide significance, and a far-larger sample would be required. The finding that no individual gene surpassed exome-wide significance in this analysis (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 4</xref></bold>), suggests that no one gene is likely to have rare variants that explain even 1% of schizophrenia cases.</p>
<p id="P22">Among genes previously reported to have potential connections between rare variants and schizophrenia, we identified an ultra-rare splice donor variant in <italic>TAF13</italic><sup><xref ref-type="bibr" rid="R12">12</xref></sup>, an ultra-rare nonsense variant in <italic>SETD1A</italic><sup><xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R17">17</xref></sup>, and a single ultra-rare nonsense variant in <italic>NRXN1</italic>, a gene in which exonic deletions associate with schizophrenia<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. We did not find any evidence of enrichment of dURVs in <italic>DPYD</italic><sup><xref ref-type="bibr" rid="R19">19</xref></sup> (in which we found two dURVs in cases and six in controls), nor in <italic>DISC1</italic><sup><xref ref-type="bibr" rid="R20">20</xref></sup> (one dURV among cases and two in controls) (<bold><xref ref-type="supplementary-material" rid="SD2">Supplementary Table 3</xref></bold>).</p>
<p id="P23">With this high level of polygenicity foreshadowed by earlier results<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R16">16</xref></sup>, it appears that definitive implication of individual genes will require sequencing still-larger numbers of exomes or whole genomes<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. We therefore focused on sets of genes with plausibly overlapping biological functions as a way of concentrating a diffuse genetic signal.</p>
</sec>
<sec id="S4">
<title>Enrichment of variants from cases in constrained genes</title>
<p id="P24">We tested gene sets for an enrichment of dURVs (in cases relative to controls) by comparing each gene set’s enrichment level to that of the average gene (<bold>Online Methods</bold>). We made this stringent correction to account for the fact that any large gene set is more likely to encompass the exome-wide excess of dURVs we see in schizophrenia cases. Our practice greatly deflates the resulting <italic>P</italic> values.</p>
<p id="P25">Subsets of human genes have been previously identified as “missense constrained” (based on a lack of functional coding variation in controls) or “loss-of-function intolerant” (based on a smaller-than-expected number of loss-of-function mutations in population-scale data)<sup><xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R21">21</xref></sup>. Similar to recent findings in autism, we observed a significant enrichment (in cases relative to controls) of dURVs in missense constrained genes<sup><xref ref-type="bibr" rid="R22">22</xref></sup> (OR=1.28; 95% CI=1.20–1.37; <italic>P</italic> = 3.2 × 10<sup>−8</sup>) and loss-of-function intolerant genes<sup><xref ref-type="bibr" rid="R8">8</xref></sup> (OR=1.17; 95% CI=1.12-1.21; <italic>P</italic> = 1.7 × 10<sup>−8</sup>) (<bold><xref ref-type="fig" rid="F2">Fig. 2</xref></bold>). Both missense constrained and loss-of-function intolerant genes were enriched for disruptive variants relative to damaging variants (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 5</xref></bold>); for the latter set, this may reflect these genes having been ascertained specifically for intolerance to disruptive mutations.</p>
<p id="P26">In contrast, genes not meeting earlier criteria for loss-of-function intolerance or missense constraint were much less enriched for dURVs (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 6</xref></bold>). This important negative control confirms that the schizophrenia-associated elevation we observe (for constrained genes) is not due to false positives disproportionally represented across disruptive and damaging variants in cases. The observed enrichment was consistent across data from previously analyzed exomes<sup><xref ref-type="bibr" rid="R9">9</xref></sup> and newly generated data (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 5</xref></bold>); as the previously analyzed exomes were sequenced across randomized batches with equal number of cases and controls in each batch, this provides additional evidence that the enrichment is not due to technical effects.</p>
</sec>
<sec id="S5">
<title>Tissues and cell types</title>
<p id="P27">The excess of dURVs could in principle be concentrated in genes expressed within specific tissues. Distinct tissues have both shared and tissue-specific sets of expressed genes. We found that a set of 2,647 genes expressed specifically in brain tissue<sup><xref ref-type="bibr" rid="R23">23</xref></sup> was strongly enriched for dURVs (OR=1.17; 95% CI=1.11–1.23; <italic>P</italic> = 1.2 × 10<sup>−4</sup>), whereas sets of genes with expression specific to other tissues (including immune cells) were not (<bold><xref ref-type="fig" rid="F3">Fig. 3a</xref></bold> and <bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 7</xref></bold>). (At the same time, the “brain-specific” genes explained only part of this signal, while a larger set of brain-expressed genes explained most of it, suggesting that much of the signal may come from genes that are expressed in brain as well as other tissues, <bold><xref ref-type="fig" rid="F3">Fig. 3a</xref></bold>). This aligns with earlier findings that SNP haplotypes implicated in schizophrenia genome-wide association studies (GWAS) tend to overlap (to a non-random degree) with sequences identified as putative enhancers in chromatin-profiling experiments on brain tissue<sup><xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R25">25</xref></sup>.</p>
<p id="P28">The brain contains a complex mixture of cell types, each of which expresses different, only partially overlapping sets of genes. To identify cell types through which rare variants might act to affect risk of schizophrenia, we evaluated (for enrichment of dURVs in affected relative to unaffected individuals) sets of genes identified as specific to neurons, astrocytes, and oligodendrocytes by earlier cell sorting and transcriptional profiling experiments<sup><xref ref-type="bibr" rid="R26">26</xref></sup>. A set of 3,388 neuron-specific genes had a strong enrichment of mutations in schizophrenia cases (OR=1.17; 95% CI=1.12–1.22; <italic>P</italic> = 1.9 × 10<sup>−7</sup>), comparable to that observed for genes specific to brain tissue itself. Genes specifically expressed in other brain cell types, such as astrocytes and oligodendrocytes, were no more enriched than the average gene (<bold><xref ref-type="fig" rid="F3">Fig. 3b</xref></bold> and <bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 8a</xref></bold>). These results nominate neurons as the central nervous system (CNS) cell type in which genetic perturbations most affect schizophrenia risk, though they do not exclude more-modest contributions from other CNS cell types.</p>
<p id="P29">Neurons are broadly classified into excitatory and inhibitory classes. The case-control excess of dURVs showed a similar degree of concentration into genes expressed in excitatory and inhibitory neurons (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 8b</xref></bold>). The small number of genes that were specific to excitatory or inhibitory neurons (relative to the other class) were insufficient to concentrate this genetic signal, which appeared to reside primarily in genes that were expressed in both neuronal classes (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 8b</xref></bold>).</p>
</sec>
<sec id="S6">
<title>Synaptic mRNAs</title>
<p id="P30">A strong and consistent finding in exome-sequencing studies of schizophrenia involves an excess of variants in genes whose mRNAs are bound by the fragile X mental retardation protein (FMRP)<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R27">27</xref></sup>. The large excess of dURVs ascertained in the current set of schizophrenia cases elevated evidence for this relationship (OR=1.23; 95% CI=1.17–1.30; <italic>P</italic> = 8.2 × 10<sup>−9</sup>).</p>
<p id="P31">The enrichment of dURVs among genes that encode FMRP-bound transcripts has multiple potential biological explanations. One potential explanation could involve the translational-inhibition capacity of FMRP, as implicit in the common description of such genes as FMRP “targets”. Another potential interpretation is that it is in fact the localization of these RNAs to neuronal processes and synapses by FMRP – its shuttling activity – that defines the important biological commonality among these genes. Yet a third possibility is that FMRP-binding experiments have simply been effective ways of ascertaining neuronally expressed genes.</p>
<p id="P32">To evaluate these possibilities, we first considered a different set of genes whose mRNAs are carried to synapses by a different shuttling protein, CELF4<sup><xref ref-type="bibr" rid="R28">28</xref></sup>. The genes encoding CELF4-bound mRNAs also showed an enrichment of dURVs in schizophrenia cases; this enrichment (OR=1.14; 95% CI=1.09–1.19; <italic>P</italic> = 6.6 × 10<sup>−4</sup>) was greater than that of the average gene though less strong than that of genes encoding FMRP-bound RNAs.</p>
<p id="P33">We also investigated whether genes encoding mRNAs that are bound by RBFOX splicing factors, known to regulate synaptic genes<sup><xref ref-type="bibr" rid="R29">29</xref></sup> and also previously observed at synapses<sup><xref ref-type="bibr" rid="R30">30</xref></sup>, could explain a substantial fraction of the dURVs. Earlier experimental work (based on the HITS-CLIP technique for identifying RNAs bound to proteins of interest) has defined constellations of genes whose RNAs are bound by RBFOX1, RBFOX2, or RBFOX3. (We considered RBFOX1 and RBFOX3 together below due to their largely overlapping sets of bound genes<sup><xref ref-type="bibr" rid="R31">31</xref></sup>). Genes whose transcripts are bound by RBFOX1 or RBFOX3 were enriched in dURVs (OR=1.16; 95% CI=1.11–1.21; <italic>P</italic> = 6.7 × 10<sup>−7</sup>). A somewhat stronger enrichment was apparent for genes whose RNAs are bound by RBFOX2 (OR=1.21; 95% CI=1.16–1.26; <italic>P</italic> = 6.3 × 10<sup>−12</sup>).</p>
<p id="P34">We also observed enrichment in synaptic genes as defined by the SynaptomeDB<sup><xref ref-type="bibr" rid="R32">32</xref></sup> (OR=1.14; 95% CI=1.09–1.20; <italic>P</italic> = 0.0022), though this smaller set of genes explained a smaller fraction of the case-control difference in dURVs (<bold><xref ref-type="fig" rid="F3">Fig. 3c</xref></bold>).</p>
<p id="P35">We were concerned that the enrichment for dURVs in genes with synaptically localized transcripts could, in principle, be simply due to these experiments having been highly effective at isolating transcripts that are present in neurons (which strongly express FMR1, CELF4, and RBFOX1/2/3); in this case, the importance of synaptic localization would be uncertain. To address this possibility, we identified, from earlier experimental data, sets of genes expressed in brain tissue<sup><xref ref-type="bibr" rid="R23">23</xref></sup>, neurons<sup><xref ref-type="bibr" rid="R26">26</xref></sup>, excitatory neurons, and inhibitory neurons<sup><xref ref-type="bibr" rid="R33">33</xref></sup>. Within each set, we defined a gene as “potentially synaptic” if it was in any of the previously constructed FMRP, CELF4, RBFOX2, or SynaptomeDB gene sets, then stratified each of the neuronal/brain expression gene sets based on whether or not the genes were potentially synaptic (<bold><xref ref-type="fig" rid="F4">Fig. 4</xref></bold>). No matter how we defined neuronally expressed genes, we observed that this tendency to contain an excess of dURVs in schizophrenia cases distinguished the potentially synaptic genes (which showed elevated rates of dURVs in schizophrenia) from other neuronally expressed genes (which did not) (<bold><xref ref-type="fig" rid="F4">Fig. 4</xref></bold>).</p>
<p id="P36">These large constellations of potentially synaptic genes appeared to explain a large fraction (collectively more than 70%) of the exome-wide enrichment in dURVs (<bold><xref ref-type="fig" rid="F4">Fig. 4</xref></bold>).</p>
</sec>
<sec id="S7">
<title>Protein complexes</title>
<p id="P37">Protein complexes have been used to define sets of genes with aligned activities, offering potentially meaningful ways to group genes for genetic analysis. We focused on genes encoding proteins that have been detected at synaptic complexes by co-immunoprecipitation with known synaptic components followed by mass spectrometric proteomic analyses. These gene sets have been the source of primary enrichment results in earlier studies of CNVs and rare and <italic>de novo</italic> SNVs in schizophrenia patients<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R34">34</xref></sup>. We observed case-control enrichment of dURVs among genes thus defined as encoding interactors with PSD-95 (OR=1.52; 95% CI 1.21–1.90; <italic>P</italic> = 0.0017), ARC and N-methyl-D-aspartate receptors (NMDAR)<sup><xref ref-type="bibr" rid="R35">35</xref></sup> (OR=1.55; 95% CI=1.21–1.98; <italic>P</italic> = 0.0028) (<bold><xref ref-type="fig" rid="F2">Fig. 2</xref></bold>). Despite these elevated levels of enrichment, these smaller gene sets explained much smaller fractions (collectively 4-12%) of the case-control enrichment in dURVs, perhaps reflecting that these gene sets include just a fraction of the proteins that are present at synapses.</p>
<p id="P38">More-complete ascertainment of the protein components of synaptic structures is an important future research direction that might advance functional analysis and interpretation of larger constellations of rare variants.</p>
</sec>
<sec id="S8">
<title>Overlap with GWAS genes and intellectual disability</title>
<p id="P39">We tested whether genes within the 108 GWAS loci recently identified in schizophrenia also contain an excess of dURVs. We observed a nominally significant enrichment in genes overlapping regions near common variants associated with schizophrenia<sup><xref ref-type="bibr" rid="R24">24</xref></sup> (OR=1.37; 95% CI=1.09–1.73; <italic>P</italic> = 0.027) (<bold><xref ref-type="fig" rid="F2">Fig. 2</xref></bold>) hinting at some degree of convergence. This overlap was greater than could be explained by any individual gene or small set of genes. Predicted targets of microRNA-137<sup><xref ref-type="bibr" rid="R36">36</xref></sup>, previously identified as localized near common SNPs associated with schizophrenia<sup><xref ref-type="bibr" rid="R37">37</xref></sup>, were also significantly enriched for dURVs (OR=1.13; 95% CI=1.09–1.18; <italic>P</italic> = 6.8 × 10<sup>−4</sup>) (<bold><xref ref-type="fig" rid="F2">Fig. 2</xref></bold>).</p>
<p id="P40">Mutations associated with intellectual disability and developmental disorders are often also substantial risk factors for syndromic forms of autism and perhaps schizophrenia<sup><xref ref-type="bibr" rid="R38">38</xref>–<xref ref-type="bibr" rid="R40">40</xref>,<xref ref-type="bibr" rid="R17">17</xref></sup>. We did observe the dURV elevation to be concentrated in X-linked intellectual disability (XLID) genes<sup><xref ref-type="bibr" rid="R41">41</xref>,<xref ref-type="bibr" rid="R42">42</xref></sup> (OR=1.88; 95% CI=1.34–2.64; <italic>P</italic> = 9.5 × 10<sup>−4</sup>) and in developmental disorder (DD) genes<sup><xref ref-type="bibr" rid="R43">43</xref></sup> (OR=1.67; 95% CI=1.31-2.13; <italic>P</italic> = 1.6 × 10<sup>−4</sup>) (<bold>Online Methods</bold>). Of potential interest, we identified four dURVs in schizophrenia cases (and none in controls) in XLID gene <italic>KDM5C</italic>, an H3K4 methylation eraser gene<sup><xref ref-type="bibr" rid="R44">44</xref></sup>, 11 dURVs in cases (and 2 in controls) in DD gene <italic>KDM5B</italic>, another H3K4 methylation eraser gene<sup><xref ref-type="bibr" rid="R45">45</xref></sup>, and 11 dURVs in cases (and 3 in controls) in DD gene <italic>ITPR1</italic>, which encodes an inositol triphosphate receptor<sup><xref ref-type="bibr" rid="R46">46</xref></sup> (<bold><xref ref-type="supplementary-material" rid="SD7">Supplementary Tables 2</xref> and <xref ref-type="supplementary-material" rid="SD2">3</xref></bold>). The enrichment of XLID variants was not different between female and male cases (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 9</xref></bold>).</p>
</sec>
<sec id="S9">
<title>Ovrelap with de novo mutations ascertained in trios</title>
<p id="P41">We further tested for enrichment of dURVs in (i) genes overlapping <italic>de novo</italic> copy number variants (CNVs) previously found in individuals with schizophrenia, bipolar disorder, and autism (<bold><xref ref-type="supplementary-material" rid="SD3">Supplementary Tables 4</xref> and <xref ref-type="supplementary-material" rid="SD4">5</xref></bold>, see <bold>Online Methods</bold>), and (ii) genes in which <italic>de novo</italic> non-synonymous mutations were previously ascertained in individuals with autism, congenital heart disease, epilepsy, intellectual disability, and schizophrenia (<bold><xref ref-type="supplementary-material" rid="SD5">Supplementary Tables 6</xref> and <xref ref-type="supplementary-material" rid="SD6">7</xref></bold>, see <bold>Online Methods</bold>). Because <italic>de novo</italic> non-synonymous mutations have been ascertained in such a large number of genes, we sought to increase specificity by restricting this analysis to loss-of-function intolerant (LoF-intolerant) genes, as previously defined<sup><xref ref-type="bibr" rid="R8">8</xref></sup>. We observed a significant enrichment in genes within <italic>de novo</italic> deletions previously ascertained in schizophrenia cases (OR=1.34; 95% CI=1.13–1.59; <italic>P</italic> = 0.0052) (<bold><xref ref-type="fig" rid="F5">Fig. 5a</xref></bold>), as well as an enrichment in loss-of-function intolerant genes with <italic>de novo</italic> non-synonymous mutations in schizophrenia cases (OR=1.41; 95% CI=1.25–1.60; <italic>P</italic> = 0.0011) (<bold><xref ref-type="fig" rid="F5">Fig. 5b</xref></bold>).</p>
</sec>
</sec>
<sec id="S10" sec-type="discussion">
<title>DISCUSSION</title>
<p id="P42">By sequencing the exomes of 12,332 unrelated individuals from Sweden, including 4,946 affected with schizophrenia, we observed an exome-wide burden of dURVs in schizophrenia cases. This excess rare-variant burden – approximately 0.25 such variants per person (on a background of 4 such variants) – was several times greater than the schizophrenia-associated elevation in rates of gene-disruptive and protein-damaging <italic>de novo</italic> mutations, suggesting that the observed excess arose mostly from inherited variants. For less-rare (segregating) variants of even modest allele frequencies, we were unable to detect any excess in affected relative to unaffected individuals, consistent with a previous analysis of non-ultra-rare exonic variants in other cohorts<sup><xref ref-type="bibr" rid="R47">47</xref></sup>.</p>
<p id="P43">The excess of dURVs in schizophrenia cases largely resided in brain-expressed genes, and more specifically in genes that are expressed in neurons, rather than in other CNS cell types (<bold><xref ref-type="fig" rid="F6">Fig. 6</xref></bold>). It is possible that earlier associations to small, protein-interaction-defined gene sets (such as PSD-95, NMDAR and ARC<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R34">34</xref></sup>), which appear to explain combined a much-smaller fraction of the exome-wide dURV burden in schizophrenia (collectively 4-12%), have been proxies for a far-wider set of rare-variant effects at synapses.</p>
<p id="P44">Most of the excess of dURVs in affected individuals’ exomes appeared to be concentrated in a larger set of genes encoding potentially synaptic proteins. Genes whose transcripts are bound by FMRP or CELF4<italic> –</italic> which transport a subset of neuronal RNAs to neuronal processes and synapses – or RBFOX2 – which regulates many synaptic RNAs and has been observed at synapses – explained considerably larger fractions (collectively more than 70%) of the global rare-variant enrichment observed in cases. Genes encoding RNAs bound by FMRP or RBFOX proteins have previously been shown to be enriched for mutations in subjects with autism and/or schizophrenia<sup><xref ref-type="bibr" rid="R48">48</xref>,<xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R49">49</xref></sup>, though it has been unclear whether such potential effects are a small or a large fraction of strongly risk-increasing variants. While it is tempting to attribute the association of schizophrenia with dURVs in FMRP–associated, CELF4–associated, and RBFOX2–associated genes to the specific biological activities of these proteins, we propose that their association may simply reflect the synaptic localization and function of the transcripts and proteins encoded by these genes.</p>
<p id="P45">We observed a significant overlap of the dURV excess with genes in which <italic>de novo</italic> non-synonymous mutations and deletions have been found in schizophrenia cases. We also observed a significant enrichment across intellectual disability genes on the X chromosome and in developmental disorder genes. This enrichment is compatible with observations of the role of intellectual disability genes in some cases of autism<sup><xref ref-type="bibr" rid="R38">38</xref>–<xref ref-type="bibr" rid="R40">40</xref></sup> and schizophrenia<sup><xref ref-type="bibr" rid="R17">17</xref></sup>, though the penetrance of such mutations for schizophrenia may be much less than their penetrance for intellectual disability, and they may reside primarily in syndromic cases in which schizophrenia is preceded by other developmental disorders<sup><xref ref-type="bibr" rid="R17">17</xref></sup>.</p>
<p id="P46">The fact that an analysis of the current scale (4,877 cases, 6,203 controls, and 45,376 other genomes used to help identify ultra-rare variants) did not implicate individual genes of large effect in an unbiased exome-wide search – while documenting a very clear exome-wide elevation of hundreds of pathogenic variants across 4,877 individuals affected with schizophrenia relative to controls – lends further support to the emerging impression that the high polygenicity of schizophrenia extends to rare as well as common variants<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R16">16</xref></sup>. Because of the rareness of these variants and the infrequency with which any individual gene is affected by them – even among schizophrenia cases – the sequencing of much larger cohorts will be needed to identify the specific individual genes in which rare variants shape risk for schizophrenia.</p>
</sec>
<sec id="S12" specific-use="web-only">
<title>ONLINE METHODS</title>
<sec id="S13">
<title>Sample collection and sequencing</title>
<p id="P48">A total of 12,384 blood-derived DNA samples from Swedish research participants were collected from 2005 to 2013. Psychiatric cases with a diagnosis of schizophrenia or bipolar disorder were ascertained from the Swedish National Hospital Discharge Register as described in previous studies<sup><xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R50">50</xref></sup>, which captures all inpatient hospitalizations. Controls were randomly selected from population registers. Excluding subjects with bipolar disorder, age information at the time of DNA sampling was available for each individual. All subjects provided informed consent; institutional human subject committees approved the research (UNC IRB # 04-1465). All procedures were approved by the ethical committees in Sweden and in the United States.</p>
<p id="P49">The 12,384 samples collected were sequenced in twelve separate waves. The first wave employed an earlier version of the hybrid-capture procedure (Agilent SureSelect Human All Exon Kit), which targets ~28 million base pairs of the human genome, partitioned in ~160,000 intervals, whereas the samples from the other waves used a newer version (Agilent SureSelect Human All Exon v.2 Kit), which targets ~32 million base pairs of the human genome, partitioned in ~190,000 intervals. The first wave was sequenced using Illumina GAII instruments and the remaining waves were sequenced using Illumina HiSeq 2000 and HiSeq 2500 instruments, with pair ended sequencing reads of 76 base pairs across all waves. Sequencing was performed at the Broad Institute of MIT and Harvard across the period of time from 2010 to 2013. With the exception of the first wave, we did not observe significant differences across waves and cases status beyond what could be explained by ancestry (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 10</xref></bold>).</p>
<p id="P50">This cohort has been previously analyzed in relation to schizophrenia for common variants<sup><xref ref-type="bibr" rid="R51">51</xref>,<xref ref-type="bibr" rid="R37">37</xref>,<xref ref-type="bibr" rid="R52">52</xref>,<xref ref-type="bibr" rid="R50">50</xref>,<xref ref-type="bibr" rid="R24">24</xref></sup> and copy number variants<sup><xref ref-type="bibr" rid="R52">52</xref>,<xref ref-type="bibr" rid="R53">53</xref></sup>, and in relation to somatic mosaic mutations<sup><xref ref-type="bibr" rid="R54">54</xref></sup>. Exome sequence data for approximately half of the individuals in the cohort had already been analyzed in relation to schizophrenia phenotype in a previous study<sup><xref ref-type="bibr" rid="R9">9</xref></sup> and in a more recent study<sup><xref ref-type="bibr" rid="R17">17</xref></sup>.</p>
</sec>
<sec id="S14">
<title>Preliminary quality control for individuals</title>
<p id="P51">Exome sequence data from 12,384 samples was aligned against the GRCh37 human genome reference with bwa aln 0.5.9<sup><xref ref-type="bibr" rid="R55">55</xref></sup> and further processed using the GATK framework<sup><xref ref-type="bibr" rid="R56">56</xref></sup>. Genotype calls were generated using GATK Haplotype Caller version 3.1-144-g00f68a3 and best practices<sup><xref ref-type="bibr" rid="R57">57</xref>,<xref ref-type="bibr" rid="R58">58</xref></sup>. Variants filtered out by the GATK Variant Quality Score Recalibration (VQSR) tool were excluded. Genotypes over sites with less than 10x sequencing coverage were set to missing. We identified and removed 4 duplicate individuals and 48 individuals with a first degree relationship (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 11</xref></bold>) with other individuals in the cohort using the plink<sup><xref ref-type="bibr" rid="R59">59</xref>,<xref ref-type="bibr" rid="R60">60</xref></sup> software. We then computed the number of ultra-rare single nucleotide polymorphysms (SNPs) and indels never observed in ExAC<sup><xref ref-type="bibr" rid="R8">8</xref></sup> for each of the remaining 12,332 samples and identified one individual with 1,757 ultra-rare SNPs and 22 ultra-rare indels from the sixth sequencing wave (see <xref ref-type="supplementary-material" rid="SD4">Supplementary Table S5F</xref> from <italic>Genovese et al.</italic><sup><xref ref-type="bibr" rid="R54">54</xref></sup>), four individuals with between 92 and 127 ultra-rare indels from the first sequencing wave, five individuals from waves 11 and 12 with between 410 and 496 ultra-rare SNPs due to African ancestry. These 10 individuals were excluded from further analysis. The resulting individuals had a range of 5-259 ultra-rare SNPs and 0-19 ultra-rare indels (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 12a</xref></bold>). We further removed 15 individuals for whom the reported sex and the inferred sex from inbreeding coefficients on the X chromosome mismatched (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 13</xref></bold>), including 7 individuals with 47, XXY karyotype (Klinefelter syndrome), and 94 individuals with more than 100 URVs.</p>
</sec>
<sec id="S15">
<title>Association with common variants</title>
<p id="P52">A logistic regression model was used to estimate association between single variants and schizophrenia phenotype correcting for sex and the first five principal components using plink<sup><xref ref-type="bibr" rid="R59">59</xref>,<xref ref-type="bibr" rid="R60">60</xref></sup>. We identified two loci (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 14</xref></bold>) with statistically significant associations (p&lt;10<sup>−6</sup>) replicating a couple of common variants associations previously observed for this cohort<sup><xref ref-type="bibr" rid="R50">50</xref></sup>: a single variant rs281766 on chromosome 2 in the UTR5 of genes <italic>TYW5</italic> and <italic>C2orf47</italic>, a variant in strong linkage disequilibrium with the seventh strongest independently associated variant in the largest meta-analysis for schizophrenia<sup><xref ref-type="bibr" rid="R24">24</xref></sup>, and seven variants in the MHC region around the HLA genes, also a region with extensive linkage to known causal variants associated with schizophrenia<sup><xref ref-type="bibr" rid="R61">61</xref></sup>.</p>
</sec>
<sec id="S16">
<title>Variant annotation</title>
<p id="P53">We annotated all genotyped variants with SnpEff 4.2 (build 2015-12-05)<sup><xref ref-type="bibr" rid="R62">62</xref></sup> using Ensembl gene models from database GRCh37.75. We further annotated variants with SnpSift 4.2 (build 2015-12-05)<sup><xref ref-type="bibr" rid="R63">63</xref></sup> using annotations from database dbNSFP 2.9<sup><xref ref-type="bibr" rid="R64">64</xref>,<xref ref-type="bibr" rid="R65">65</xref></sup>. Variants identified within transcripts from UCSC known genes<sup><xref ref-type="bibr" rid="R66">66</xref></sup> were further classified into four groups:</p>
<list id="L2" list-type="bullet">
<list-item>
<p id="P54"><italic>synonymous</italic>: whenever classified with synonymous effect by SnpEff</p>
</list-item>
<list-item>
<p id="P55"><italic>missense non-damaging</italic>: whenever classified with missense effect but not classified as <italic>damaging</italic> (by the criteria below)</p>
</list-item>
<list-item>
<p id="P56">putatively protein-<italic>damaging</italic>: whenever classified with MODERATE impact by SnpEff and further predicted as damaging by each among SIFT<sup><xref ref-type="bibr" rid="R67">67</xref></sup>, PolyPhen-2<sup><xref ref-type="bibr" rid="R68">68</xref></sup>, LRT<sup><xref ref-type="bibr" rid="R69">69</xref></sup>, Mutation Taster<sup><xref ref-type="bibr" rid="R70">70</xref></sup>, Mutation Assessor<sup><xref ref-type="bibr" rid="R71">71</xref></sup>, and PROVEAN<sup><xref ref-type="bibr" rid="R72">72</xref></sup> algorithms or classified as either in-frame indels or protein-protein-contact variants<sup><xref ref-type="bibr" rid="R73">73</xref></sup></p>
</list-item>
<list-item>
<p id="P57">gene <italic>disruptive</italic>: whenever classified with HIGH impact by SnpEff with the exclusion of protein-protein-contact variants</p>
</list-item>
</list>
<p id="P58">Notice that FATHMM<sup><xref ref-type="bibr" rid="R74">74</xref></sup> predictions included in dbNSFP were not used due to poor performance with respect to minor allele count (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 1</xref></bold>) and a small number of variants defined as damaging by the predictor (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 3b</xref></bold>). The final predictor performed better than all other individual predictors (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 3b</xref></bold>) but it was not overfit as to be the best predictor for this cohort (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 15</xref></bold>).</p>
</sec>
<sec id="S17">
<title>Estimation of principal components</title>
<p id="P59">Out of a total of 1,753,312 variants passing VQSR filters, 66,874 were identified as in common with variants from the 1000 Genomes project phase 1 dataset<sup><xref ref-type="bibr" rid="R75">75</xref></sup> and included as part of the Omni2.5 genotype array. We used this subset of highly confident variants to estimate population stratification. We selected exclusively Omni2.5 polymorphic sites because more robust in the 1000 Genomes dataset to artifacts due to the heterogeneity of the sequencing technologies used within the 1000 Genomes project. We then further restricted to variants with minor allele frequency larger than 1% in both the Sweden and the 1000 Genomes dataset and we pruned for variants in linkage disequilibrium using plink<sup><xref ref-type="bibr" rid="R59">59</xref>,<xref ref-type="bibr" rid="R60">60</xref></sup> (with command line '--indep 50 5 2'). We then merged the Sweden and the 1000 Genomes dataset and computed principal components using plink and GCTA<sup><xref ref-type="bibr" rid="R76">76</xref></sup> (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 12c-d</xref></bold>). Estimated 3<sup>rd</sup> and 5<sup>th</sup> principal components corresponded to previously observed Finnish and Northern-Southern Sweden clines<sup><xref ref-type="bibr" rid="R12">12</xref></sup> (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 12d</xref></bold>), while 1<sup>st</sup>, 2<sup>nd</sup>, and 4<sup>th</sup> principal components corresponded to the three main principal components in the 1000 Genomes project phase 1 distinguishing African, East Asian, and Native American ancestry. While principal components did correlate with overall amounts of URVs (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 12e-f</xref></bold>), rather than removing individuals with exotic ancestry based on principal components loading, we simply removed individuals with more than 100 URVs and we included sex, year of birth (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 12b</xref></bold>), exome capturing kit, the first 20 principal component loadings, and the total number of URVs for each individual as covariates in all statistical analysis involving URVs and dURVs.</p>
</sec>
<sec id="S18">
<title>Quality control for common variants</title>
<p id="P60">Variants were excluded whether failing the GATK VQSR tool (117,629 variants), having inbreeding coefficient less than zero (that is, more observed heterozygotes than expected) while at the same time failing a Hardy-Weinberg disequilibrium test with a false discovery rate of 10<sup>−6</sup> (8,306 additional variants), or whether associating with any of the 146 batches among which the cohort was split for sequencing in the sequencing facility at the Broad Institute (3,700 additional variants). Due to prevalent population stratification within batches, we estimated unusual associations with a logistic regression model including sex and the first 20 principal components loadings as covariates.</p>
</sec>
<sec id="S19">
<title>Excess of dURVs</title>
<p id="P61">For each gene set, to estimate the excess of dURVs in cases with schizophrenia (or the odds ratios for schizophrenia phenotype) we used a linear (or logistic) regression model correcting for: (i) sex; (ii) overall URV count; (iii) birth year; (iv) the hybrid selection kit used to enrich for exome sequence; and (v) the first twenty principal components estimated from exome-wide SNP genotypes. When estimating <italic>P</italic> values, to estimate the importance of each gene set with respect to the observed exome-wide enrichment, we further corrected for exome-wide dURV count. This expedient allows to better estimate the importance of each gene set irrespectively of its size and to answer the more precise question of whether a gene set concentrates the exome-wide dURV enrichment better than the average gene.</p>
</sec>
<sec id="S20">
<title>Construction of gene sets</title>
<p id="P62">We used different resources to build the gene sets for which the burden of dURVs was computed:</p>
<list id="L3" list-type="order">
<list-item>
<p id="P63">For missense constrained genes we used genes from <xref ref-type="supplementary-material" rid="SD7">supplementary table 2</xref> of <italic>Samocha et al.</italic><sup><xref ref-type="bibr" rid="R22">22</xref></sup>.</p>
</list-item>
<list-item>
<p id="P64">For loss-of-function intolerant (LoF-intolerant) genes we used genes from <italic>Lek et al.</italic><sup><xref ref-type="bibr" rid="R8">8</xref></sup> available online (<ext-link ext-link-type="ftp" xlink:href="ftp://ftp.broadinstitute.org/pub/ExAC_release/release0.3/functional_gene_constraint/">ftp://ftp.broadinstitute.org/pub/ExAC_release/release0.3/functional_gene_constraint/</ext-link>).</p>
</list-item>
<list-item>
<p id="P65">For genes with expression specific to the brain, we used expression table from supplementary data set 1 of <italic>Fagerberg et al.</italic><sup><xref ref-type="bibr" rid="R23">23</xref></sup> and we selected genes for which expression in brain was four times higher than the median expression across all 27 different tissues (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 7</xref></bold>).</p>
</list-item>
<list-item>
<p id="P66">For brain genes with expression specific to neurons, we used expression table from <xref ref-type="supplementary-material" rid="SD2">supplementary table S3b</xref> of <italic>Cahoy et al.</italic><sup><xref ref-type="bibr" rid="R26">26</xref></sup> and we selected genes for which log-expression in Neurons P7n cell type was 0.5 greater than the median log-expression across 11 central nervous system cell types (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 8a</xref></bold>).</p>
</list-item>
<list-item>
<p id="P67">For RBFOX2 and RBFOX1/3 gene sets we selected genes from <xref ref-type="supplementary-material" rid="SD7">supplementary table S1</xref> of <italic>Weyn-Vanhentenryck et al.</italic><sup><xref ref-type="bibr" rid="R31">31</xref></sup> for which at least, respectively, one Rbfox2 tag count was measured greater than or equal to 4, and one of the sum of Rbfox1 and Rbfox3 tag counts was greater than or equal to 12. A single gene set was generated for RBFOX1 and RBFOX3 due to high correlation between tag counts for the two genes.</p>
</list-item>
<list-item>
<p id="P68">Instead of using the classical FMRP Darnell gene set of 842 mouse genes from <xref ref-type="supplementary-material" rid="SD2">supplementary table S2A</xref> of <italic>Darnell et al.</italic><sup><xref ref-type="bibr" rid="R27">27</xref></sup> including all genes with FDR&lt;0.01, we used a larger gene set of 1,285 mouse genes from <xref ref-type="supplementary-material" rid="SD2">supplementary table S2C</xref> of <italic>Darnell et al.</italic><sup><xref ref-type="bibr" rid="R27">27</xref></sup> including genes with FDR&lt;0.1.</p>
</list-item>
<list-item>
<p id="P69">For CELF4 we used genes with “iCLIP occupancy” greater than 0.2 from <xref ref-type="supplementary-material" rid="SD3">supplementary table S4</xref> of <italic>Wagnon et al.</italic><sup><xref ref-type="bibr" rid="R28">28</xref></sup>.</p>
</list-item>
<list-item>
<p id="P70">To create a gene set with synaptic genes we included 1,887 genes from the SynaptomeDB<sup><xref ref-type="bibr" rid="R32">32</xref></sup> from the presynaptic proteins, presynaptic activezone, synaptic vesicles, and postsynaptic density categories.</p>
</list-item>
<list-item>
<p id="P71">To create a set of genes expressed in brain, we used expression table from supplementary data set 1 of <italic>Fagerberg et al.</italic><sup><xref ref-type="bibr" rid="R23">23</xref></sup> and we selected genes for which fragments per kilobase of transcript per million (FPKM) in brain was larger than 5.</p>
</list-item>
<list-item>
<p id="P72">To create a set of genes expressed in neurons, we used expression table from <xref ref-type="supplementary-material" rid="SD2">supplementary table S3b</xref> of <italic>Cahoy et al.</italic><sup><xref ref-type="bibr" rid="R26">26</xref></sup> and we selected genes for which log-expression in Neurons P7n cell type was larger than 9.</p>
</list-item>
<list-item>
<p id="P73">To create sets of genes expressed in excitatory and inhibitory neurons, we used expression table from <xref ref-type="supplementary-material" rid="SD7">Table S2</xref> of <italic>Mo et al.</italic><sup><xref ref-type="bibr" rid="R33">33</xref></sup> and we selected genes for which the average transcripts per million (TPM) of, respectively, excitatory pyramidal neurons and inhibitory neurons, the latter including parvalbumin (PV)-expressing fast-spiking or vasoactive intestinal peptide (VIP)-expressing interneurons, was larger than 50. Similarly for sets of genes specific for each neuron type, we selected genes expressed more than 5 times the minimum expression observed across all types (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 8b</xref></bold>).</p>
</list-item>
<list-item>
<p id="P74">To generate a list of predicted targets of microRNA-137, we used human targets with good mirSVR score from <italic>Betel at al.</italic><sup><xref ref-type="bibr" rid="R36">36</xref></sup> available online (<ext-link ext-link-type="uri" xlink:href="http://www.microrna.org/">http://www.microrna.org/</ext-link>).</p>
</list-item>
<list-item>
<p id="P75">To generate PSD-95 complex gene sets, we used a gene list generated from human cortex biopsy data<sup><xref ref-type="bibr" rid="R35">35</xref></sup> available online (<ext-link ext-link-type="uri" xlink:href="http://www.genes2cognition.org/db/GeneList/L00000049">http://www.genes2cognition.org/db/GeneList/L00000049</ext-link>).</p>
</list-item>
<list-item>
<p id="P76">To compute a combined NMDAR and ARC complexes gene set, we used genes from Table S9 of <italic>Kirov et al.</italic><sup><xref ref-type="bibr" rid="R34">34</xref></sup>.</p>
</list-item>
<list-item>
<p id="P77">For genes implicated in common variant association studies, we used genes overlapping 62 regions from the 108 regions known to be associated with schizophrenia<sup><xref ref-type="bibr" rid="R24">24</xref></sup>, for which the overlap yielded at most four genes.</p>
</list-item>
<list-item>
<p id="P78">To generate genes involved in X-linked intellectual disability (XLID) we used gene lists available online (see next section).</p>
</list-item>
<list-item>
<p id="P79">To generate genes involved in developmental disorder, we selected genes from <xref ref-type="supplementary-material" rid="SD2">supplementary table 3</xref> of McRae et al.<sup><xref ref-type="bibr" rid="R43">43</xref></sup>.</p>
</list-item>
<list-item>
<p id="P80">For genes implicated in <italic>de novo</italic> CNV studies, we used genes overlapping <italic>de novo</italic> deletions and duplications identified in autism<sup><xref ref-type="bibr" rid="R77">77</xref>–<xref ref-type="bibr" rid="R84">84</xref></sup> and identified in bipolar disorder and schizophrenia<sup><xref ref-type="bibr" rid="R34">34</xref>,<xref ref-type="bibr" rid="R85">85</xref>–<xref ref-type="bibr" rid="R88">88</xref></sup> cases (<bold><xref ref-type="supplementary-material" rid="SD3">Supplementary Tables 4</xref> and <xref ref-type="supplementary-material" rid="SD4">5</xref></bold>).</p>
</list-item>
<list-item>
<p id="P81">For genes implicated in <italic>de novo</italic> nonsynonymous mutations from exome sequencing studies, we used genes identified as mutated in autism<sup><xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R49">49</xref>,<xref ref-type="bibr" rid="R89">89</xref>,<xref ref-type="bibr" rid="R90">90</xref></sup>, epilepsy<sup><xref ref-type="bibr" rid="R91">91</xref>,<xref ref-type="bibr" rid="R92">92</xref></sup>, congenital heart disease<sup><xref ref-type="bibr" rid="R93">93</xref></sup>, intellectual disability<sup><xref ref-type="bibr" rid="R94">94</xref>–<xref ref-type="bibr" rid="R97">97</xref></sup>, and schizophrenia<sup><xref ref-type="bibr" rid="R98">98</xref>,<xref ref-type="bibr" rid="R19">19</xref>,<xref ref-type="bibr" rid="R99">99</xref>,<xref ref-type="bibr" rid="R100">100</xref>,<xref ref-type="bibr" rid="R12">12</xref></sup> (<bold><xref ref-type="supplementary-material" rid="SD5">Supplementary Tables 6</xref> and <xref ref-type="supplementary-material" rid="SD6">7</xref></bold>).</p>
</list-item>
</list>
</sec>
<sec id="S21">
<title>Enrichment in X-linked intellectual disability genes</title>
<p id="P82">We used three different resources available online to define X-linked intellectual disability (XLID) genes:</p>
<list id="L4" list-type="bullet">
<list-item>
<p id="P83">XLID OMIM genes were defined as those genes causing mental retardation phenotype in the OMIM database<sup><xref ref-type="bibr" rid="R101">101</xref></sup> (<ext-link ext-link-type="uri" xlink:href="http://omim.org/geneMap/X">http://omim.org/geneMap/X</ext-link>)</p>
</list-item>
<list-item>
<p id="P84">XLID GCC genes were defined as those genes tested by the Greenwood Genetic Center<sup><xref ref-type="bibr" rid="R102">102</xref></sup> (<ext-link ext-link-type="uri" xlink:href="http://www.ggc.org/diagnostic/tests-costs/test-finder/test-finder.html?id=242">http://www.ggc.org/diagnostic/tests-costs/test-finder/test-finder.html?id=242</ext-link>).</p>
</list-item>
<list-item>
<p id="P85">XLID Chicago genes were those tested by the Genetic Services Laboratories of the university of Chicago<sup><xref ref-type="bibr" rid="R103">103</xref>,<xref ref-type="bibr" rid="R41">41</xref>,<xref ref-type="bibr" rid="R42">42</xref>,<xref ref-type="bibr" rid="R104">104</xref></sup> (<ext-link ext-link-type="uri" xlink:href="http://dnatesting.uchicago.edu/tests/x-linked-non-specific-intellectual-disability-sequencing-panel">http://dnatesting.uchicago.edu/tests/x-linked-non-specific-intellectual-disability-sequencing-panel</ext-link>).</p>
</list-item>
</list>
<p id="P86">We tested for enrichment of dURVs in the above gene sets and in genes including all of the above gene sets, and seperately genes believed to escape and not escape X-inactivation in humans<sup><xref ref-type="bibr" rid="R105">105</xref></sup>, genes from OMIM including autosomal genes causing intellectual disability, and genes involved in developmental disorders through de novo mutations<sup><xref ref-type="bibr" rid="R43">43</xref></sup>. We tested for enrichment separately in males and females, as well as combined (<bold><xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 9</xref></bold>).</p>
<p id="P87">While XLID genes and developmental disorders genes were strongly enriched in schizophrenia cases, autosomally linked intellectually disability genes were not. This discrepancy might reflect a better characterization of intellectual disability genes on the X chromosome due to a more straightforward study design for how these genes where discovered. We also observed that XLID genes which escape X-inactivation were more enriched than other XLID genes. This might reflect a disproportionate contribution to intellectual disability and psychosis from dosage sensitive brain-related genes on the X chromosome<sup><xref ref-type="bibr" rid="R106">106</xref>–<xref ref-type="bibr" rid="R108">108</xref></sup>. We did not observe a difference in effect sizes between males and females.</p>
<p id="P88">Similarly to rare variants enrichment, common variants associated with schizophrenia are localized near XLID genes <italic>CNKSR2</italic> and <italic>NLGN4X</italic>, both of which escape X inactivation, as well as non-XLID gene <italic>PJA1</italic><sup><xref ref-type="bibr" rid="R24">24</xref></sup>.</p>
</sec>
<sec id="S22">
<title>No detectable enrichment of less-rare variants</title>
<p id="P89">Given the strong case-control enrichment of dURVs in potentially synaptic genes, we used these genes to perform a sensitive evaluation of whether we could observe an increased burden of less-rare disruptive and damaging variants in the same set. Using a standard burden test for non-ultra-rare variants with minor allele count 10 or less and controlling for covariates, we observed no statistically significant enrichment of disruptive and damaging variants in schizophrenia cases compared to controls (<italic>P</italic> = 0.59), wheareas the same test was highly significant when restricted to URVs (<italic>P</italic> = 1.7 × 10<sup>−19</sup>, without controlling for exome-wide enrichment) (<bold><xref ref-type="supplementary-material" rid="SD7">Supplementary Table 8</xref></bold>).</p>
</sec>
<sec id="S23">
<title>Variance explained</title>
<p id="P90">While a predictor based on common variants<sup><xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R109">109</xref></sup> explained 15% of the variance in schizophrenia liability in this cohort, a predictor based on the cumulative burden of dURVs in all genes explained only 0.48% (<italic>P</italic> = 1.5 × 10<sup>−10</sup>), and a similar predictor in potentially synaptic genes explained only 0.92% (Nagelkerke's coefficient of determination) (<italic>P</italic> = 6.3 × 10<sup>−19</sup>). We also attempted to generate a polygenic score based on the cumulative number of dURVs in genes that had burden of dURVs in cases greater than or equal to controls. Using a leave-one-out strategy, the resulting predictor explained 0.47% (<italic>P</italic> = 2.3 × 10<sup>−10</sup>) of the phenotypic variability. These estimates are naturally lower bounds on the effect of rare variants; knowledge of the correct effect size of each variant would significantly increase the predictive value of dURVs, though obtaining such knowledge will require sequencing a vastly larger number of exomes.</p>
</sec>
</sec>
<sec id="SM" sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>supp_figs</label>
<media id="d37e1832" orientation="portrait" position="anchor" xlink:href="NIHMS815183-supplement-supp_figs.doc" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>supp_table3</label>
<media id="d37e1836" orientation="portrait" position="anchor" xlink:href="NIHMS815183-supplement-supp_table3.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD3">
<label>supp_table4</label>
<media id="d37e1840" orientation="portrait" position="anchor" xlink:href="NIHMS815183-supplement-supp_table4.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD4">
<label>supp_table5</label>
<media id="d37e1844" orientation="portrait" position="anchor" xlink:href="NIHMS815183-supplement-supp_table5.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD5">
<label>supp_table6</label>
<media id="d37e1848" orientation="portrait" position="anchor" xlink:href="NIHMS815183-supplement-supp_table6.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD6">
<label>supp_table7</label>
<media id="d37e1852" orientation="portrait" position="anchor" xlink:href="NIHMS815183-supplement-supp_table7.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD7">
<label>supp_tables1,2,8</label>
<media id="d37e1856" orientation="portrait" position="anchor" xlink:href="NIHMS815183-supplement-supp_tables1_2_8.pdf" xlink:type="simple"></media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S24">
<title>ACKNOWLEDGEMENTS</title>
<p>We thank C. Usher for comments on the manuscript and work on the figures. This study was supported by grants from the National Human Genome Research Institute (U54 HG003067, R01 HG006855 to S.A.M.), the National Institute of Mental Health (R01 MH077139 to P.F.S. and RC2 MH089905), the Stanley Center for Psychiatric Research, the Alexander and Margaret Stewart Trust, and the Sylvan C. Herman Foundation.</p>
</ack>
<fn-group>
<fn id="FN1">
<p id="P91">Reprints and permissions information is available online at <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/reprints/index.html">http://www.nature.com/reprints/index.html</ext-link>.</p>
</fn>
<fn id="FN2">
<p id="P92"><bold>Accession codes</bold> dbGaP: phs000473.</p>
</fn>
<fn id="FN3">
<p id="P93">Note: Any Supplementary Information and Source Data files are available in the online version of the paper.</p>
</fn>
<fn id="FN4">
<p id="P94">AUTHOR CONTRIBUTIONS</p>
<p id="P95">G.G. and S.A.M. designed the analyses and wrote early drafts of the manuscript. G.G. performed the analyses. M.F. contributed to analyses of <italic>de novo</italic> mutated genes, D.M.R and E.A.S. contributed with the specific design of the analyses. K.C. contributed with sample processing and data management, M.L., J.L.M., S.M.P., P.S., P.F.S., and C.M.H. contributed with sample and phenotpye collection. All authors contributed to interpretation of the findings and revisions of the manuscript.</p>
</fn>
<fn id="FN5">
<p id="P96">COMPETING FINANCIAL INTERESTS</p>
<p id="P97">The authors declare no competing financial interests.</p>
</fn>
<fn id="FN6">
<p id="P98">Data availability</p>
<p id="P99">Scripts used to perform all of the analyses are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/freeseek/gwaspipeline">https://github.com/freeseek/gwaspipeline</ext-link> and data are available through dbGAP at <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000473">http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000473</ext-link></p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGrath</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Saha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chant</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Welham</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Schizophrenia: a concise overview of incidence, prevalence, and mortality</article-title>
<source/>Epidemiol. Rev
          <year>2008</year>
<volume>30</volume>
<fpage>67</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="pmid">18480098</pub-id>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sullivan</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Kendler</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies</article-title>
<source/>Arch. Gen. Psychiatry
          <year>2003</year>
<volume>60</volume>
<fpage>1187</fpage>
<lpage>1192</lpage>
<pub-id pub-id-type="pmid">14662550</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lichtenstein</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study</article-title>
<source/>Lancet Lond. Engl
          <year>2009</year>
<volume>373</volume>
<fpage>234</fpage>
<lpage>239</lpage>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bundy</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Stahl</surname>
<given-names>D</given-names>
</name>
<name>
<surname>MacCabe</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>A systematic review and meta-analysis of the fertility of patients with schizophrenia and their unaffected relatives</article-title>
<source/>Acta Psychiatr. Scand
          <year>2011</year>
<volume>123</volume>
<fpage>98</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="pmid">20958271</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Power</surname>
<given-names>RA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings</article-title>
<source/>JAMA Psychiatry
          <year>2013</year>
<volume>70</volume>
<fpage>22</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">23147713</pub-id>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuk</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Searching for missing heritability: designing rare variant association studies</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A
          <year>2014</year>
<volume>111</volume>
<fpage>E455</fpage>
<lpage>464</lpage>
<pub-id pub-id-type="pmid">24443550</pub-id>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefansson</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CNVs conferring risk of autism or schizophrenia affect cognition in controls</article-title>
<source/>Nature
          <year>2014</year>
<volume>505</volume>
<fpage>361</fpage>
<lpage>366</lpage>
<pub-id pub-id-type="pmid">24352232</pub-id>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lek</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>
<source/>Nature
          <year>2016</year>
<volume>536</volume>
<fpage>285</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="pmid">27535533</pub-id>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purcell</surname>
<given-names>SM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A polygenic burden of rare disruptive mutations in schizophrenia</article-title>
<source/>Nature
          <year>2014</year>
<volume>506</volume>
<fpage>185</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="pmid">24463508</pub-id>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacArthur</surname>
<given-names>DG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A systematic survey of loss-of-function variants in human protein-coding genes</article-title>
<source/>Science
          <year>2012</year>
<volume>335</volume>
<fpage>823</fpage>
<lpage>828</lpage>
<pub-id pub-id-type="pmid">22344438</pub-id>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maquat</surname>
<given-names>LE</given-names>
</name>
</person-group>
<article-title>Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics</article-title>
<source/>Nat. Rev. Mol. Cell Biol
          <year>2004</year>
<volume>5</volume>
<fpage>89</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="pmid">15040442</pub-id>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fromer</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in schizophrenia implicate synaptic networks</article-title>
<source/>Nature
          <year>2014</year>
<volume>506</volume>
<fpage>179</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="pmid">24463507</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iossifov</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The contribution of de novo coding mutations to autism spectrum disorder</article-title>
<source/>Nature
          <year>2014</year>
<volume>515</volume>
<fpage>216</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="pmid">25363768</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ionita-Laza</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Makarov</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Sequence kernel association tests for the combined effect of rare and common variants</article-title>
<source/>Am. J. Hum. Genet
          <year>2013</year>
<volume>92</volume>
<fpage>841</fpage>
<lpage>853</lpage>
<pub-id pub-id-type="pmid">23684009</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purcell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cherny</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Sham</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits</article-title>
<source/>Bioinforma. Oxf. Engl
          <year>2003</year>
<volume>19</volume>
<fpage>149</fpage>
<lpage>150</lpage>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takata</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene</article-title>
<source/>Neuron
          <year>2014</year>
<volume>82</volume>
<fpage>773</fpage>
<lpage>780</lpage>
<pub-id pub-id-type="pmid">24853937</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders</article-title>
<source/>Nat. Neurosci
          <year>2016</year>
<volume>19</volume>
<fpage>571</fpage>
<lpage>577</lpage>
<pub-id pub-id-type="pmid">26974950</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rujescu</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of the neurexin 1 gene is associated with schizophrenia</article-title>
<source/>Hum. Mol. Genet
          <year>2009</year>
<volume>18</volume>
<fpage>988</fpage>
<lpage>996</lpage>
<pub-id pub-id-type="pmid">18945720</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia</article-title>
<source/>Nat. Genet
          <year>2012</year>
<volume>44</volume>
<fpage>1365</fpage>
<lpage>1369</lpage>
<pub-id pub-id-type="pmid">23042115</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Millar</surname>
<given-names>JK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of two novel genes by a translocation co-segregating with schizophrenia</article-title>
<source/>Hum. Mol. Genet
          <year>2000</year>
<volume>9</volume>
<fpage>1415</fpage>
<lpage>1423</lpage>
<pub-id pub-id-type="pmid">10814723</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Convergence of genes and cellular pathways dysregulated in autism spectrum disorders</article-title>
<source/>Am. J. Hum. Genet
          <year>2014</year>
<volume>94</volume>
<fpage>677</fpage>
<lpage>694</lpage>
<pub-id pub-id-type="pmid">24768552</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samocha</surname>
<given-names>KE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A framework for the interpretation of de novo mutation in human disease</article-title>
<source/>Nat. Genet
          <year>2014</year>
<volume>46</volume>
<fpage>944</fpage>
<lpage>950</lpage>
<pub-id pub-id-type="pmid">25086666</pub-id>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fagerberg</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics</article-title>
<source/>Mol. Cell. Proteomics MCP
          <year>2014</year>
<volume>13</volume>
<fpage>397</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="pmid">24309898</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab>
</person-group>
<article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title>
<source/>Nature
          <year>2014</year>
<volume>511</volume>
<fpage>421</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="pmid">25056061</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finucane</surname>
<given-names>HK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Partitioning heritability by functional annotation using genome-wide association summary statistics</article-title>
<source/>Nat. Genet
          <year>2015</year>
<volume>47</volume>
<fpage>1228</fpage>
<lpage>1235</lpage>
<pub-id pub-id-type="pmid">26414678</pub-id>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cahoy</surname>
<given-names>JD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function</article-title>
<source/>J. Neurosci. Off. J. Soc. Neurosci
          <year>2008</year>
<volume>28</volume>
<fpage>264</fpage>
<lpage>278</lpage>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darnell</surname>
<given-names>JC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism</article-title>
<source/>Cell
          <year>2011</year>
<volume>146</volume>
<fpage>247</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="pmid">21784246</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagnon</surname>
<given-names>JL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CELF4 regulates translation and local abundance of a vast set of mRNAs, including genes associated with regulation of synaptic function</article-title>
<source/>PLoS Genet
          <year>2012</year>
<volume>8</volume>
<fpage>e1003067</fpage>
<pub-id pub-id-type="pmid">23209433</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J-A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cytoplasmic Rbfox1 Regulates the Expression of Synaptic and Autism-Related Genes</article-title>
<source/>Neuron
          <year>2016</year>
<volume>89</volume>
<fpage>113</fpage>
<lpage>128</lpage>
<pub-id pub-id-type="pmid">26687839</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamada</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Biochemical and morphological characterization of A2BP1 in neuronal tissue</article-title>
<source/>J. Neurosci. Res
          <year>2013</year>
<volume>91</volume>
<fpage>1303</fpage>
<lpage>1311</lpage>
<pub-id pub-id-type="pmid">23918472</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weyn-Vanhentenryck</surname>
<given-names>SM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism</article-title>
<source/>Cell Rep
          <year>2014</year>
<volume>6</volume>
<fpage>1139</fpage>
<lpage>1152</lpage>
<pub-id pub-id-type="pmid">24613350</pub-id>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pirooznia</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SynaptomeDB: an ontology-based knowledgebase for synaptic genes</article-title>
<source/>Bioinforma. Oxf. Engl
          <year>2012</year>
<volume>28</volume>
<fpage>897</fpage>
<lpage>899</lpage>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mo</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epigenomic Signatures of Neuronal Diversity in the Mammalian Brain</article-title>
<source/>Neuron
          <year>2015</year>
<volume>86</volume>
<fpage>1369</fpage>
<lpage>1384</lpage>
<pub-id pub-id-type="pmid">26087164</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirov</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia</article-title>
<source/>Mol. Psychiatry
          <year>2012</year>
<volume>17</volume>
<fpage>142</fpage>
<lpage>153</lpage>
<pub-id pub-id-type="pmid">22083728</pub-id>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayés</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of the proteome, diseases and evolution of the human postsynaptic density</article-title>
<source/>Nat. Neurosci
          <year>2011</year>
<volume>14</volume>
<fpage>19</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="pmid">21170055</pub-id>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Koppal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Agius</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sander</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Leslie</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites</article-title>
<source/>Genome Biol
          <year>2010</year>
<volume>11</volume>
<fpage>R90</fpage>
<pub-id pub-id-type="pmid">20799968</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium</collab>
</person-group>
<article-title>Genome-wide association study identifies five new schizophrenia loci</article-title>
<source/>Nat. Genet
          <year>2011</year>
<volume>43</volume>
<fpage>969</fpage>
<lpage>976</lpage>
<pub-id pub-id-type="pmid">21926974</pub-id>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>EB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autism spectrum disorder severity reflects the average contribution of de novo and familial influences</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A
          <year>2014</year>
<volume>111</volume>
<fpage>15161</fpage>
<lpage>15165</lpage>
<pub-id pub-id-type="pmid">25288738</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Genetic research in autism spectrum disorders</article-title>
<source/>Curr. Opin. Pediatr
          <year>2015</year>
<volume>27</volume>
<fpage>685</fpage>
<lpage>691</lpage>
<pub-id pub-id-type="pmid">26371945</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>EB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic risk for autism spectrum disorders and neuropsychiatric variation in the general population</article-title>
<source/>Nat. Genet
          <year>2016</year>
<volume>48</volume>
<fpage>552</fpage>
<lpage>555</lpage>
<pub-id pub-id-type="pmid">26998691</pub-id>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moeschler</surname>
<given-names>JB</given-names>
</name>
</person-group>
<article-title>Genetic evaluation of intellectual disabilities</article-title>
<source/>Semin. Pediatr. Neurol
          <year>2008</year>
<volume>15</volume>
<fpage>2</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">18342255</pub-id>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gécz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shoubridge</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Corbett</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The genetic landscape of intellectual disability arising from chromosome X</article-title>
<source/>Trends Genet. TIG
          <year>2009</year>
<volume>25</volume>
<fpage>308</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="pmid">19556021</pub-id>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McRae</surname>
<given-names>JF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence, phenotype and architecture of developmental disorders caused by de novo mutation</article-title>
<source/>bioRxiv
          <year>2016</year>
<fpage>49056</fpage>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname>
<given-names>LR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation</article-title>
<source/>Am. J. Hum. Genet
          <year>2005</year>
<volume>76</volume>
<fpage>227</fpage>
<lpage>236</lpage>
<pub-id pub-id-type="pmid">15586325</pub-id>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiang</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A
          <year>2007</year>
<volume>104</volume>
<fpage>19226</fpage>
<lpage>19231</lpage>
<pub-id pub-id-type="pmid">18048344</pub-id>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsumoto</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor</article-title>
<source/>Nature
          <year>1996</year>
<volume>379</volume>
<fpage>168</fpage>
<lpage>171</lpage>
<pub-id pub-id-type="pmid">8538767</pub-id>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richards</surname>
<given-names>AL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exome arrays capture polygenic rare variant contributions to schizophrenia</article-title>
<source/>Hum. Mol. Genet
          <year>2016</year>
<volume>25</volume>
<fpage>1001</fpage>
<lpage>1007</lpage>
<pub-id pub-id-type="pmid">26740555</pub-id>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iossifov</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo gene disruptions in children on the autistic spectrum</article-title>
<source/>Neuron
          <year>2012</year>
<volume>74</volume>
<fpage>285</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="pmid">22542183</pub-id>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Rubeis</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>
<source/>Nature
          <year>2014</year>
<volume>515</volume>
<fpage>209</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="pmid">25363760</pub-id>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ripke</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide association analysis identifies 13 new risk loci for schizophrenia</article-title>
<source/>Nat. Genet
          <year>2013</year>
<volume>45</volume>
<fpage>1150</fpage>
<lpage>1159</lpage>
<pub-id pub-id-type="pmid">23974872</pub-id>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>International Schizophrenia Consortium</collab>
<etal></etal>
</person-group>
<article-title>Common polygenic variation contributes to risk of schizophrenia and bipolar disorder</article-title>
<source/>Nature
          <year>2009</year>
<volume>460</volume>
<fpage>748</fpage>
<lpage>752</lpage>
<pub-id pub-id-type="pmid">19571811</pub-id>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergen</surname>
<given-names>SE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder</article-title>
<source/>Mol. Psychiatry
          <year>2012</year>
<volume>17</volume>
<fpage>880</fpage>
<lpage>886</lpage>
<pub-id pub-id-type="pmid">22688191</pub-id>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szatkiewicz</surname>
<given-names>JP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Copy number variation in schizophrenia in Sweden</article-title>
<source/>Mol. Psychiatry
          <year>2014</year>
<volume>19</volume>
<fpage>762</fpage>
<lpage>773</lpage>
<pub-id pub-id-type="pmid">24776740</pub-id>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Genovese</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence</article-title>
<source/>N. Engl. J. Med
          <year>2014</year>
<volume>371</volume>
<fpage>2477</fpage>
<lpage>2487</lpage>
<pub-id pub-id-type="pmid">25426838</pub-id>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Durbin</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Fast and accurate short read alignment with Burrows–Wheeler transform</article-title>
<source/>Bioinformatics
          <year>2009</year>
<volume>25</volume>
<fpage>1754</fpage>
<lpage>1760</lpage>
<pub-id pub-id-type="pmid">19451168</pub-id>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKenna</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data</article-title>
<source/>Genome Res
          <year>2010</year>
<volume>20</volume>
<fpage>1297</fpage>
<pub-id pub-id-type="pmid">20644199</pub-id>
</element-citation>
</ref>
<ref id="R57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DePristo</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A framework for variation discovery and genotyping using next-generation DNA sequencing data</article-title>
<source/>Nat. Genet
          <year>2011</year>
<volume>43</volume>
<fpage>491</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="pmid">21478889</pub-id>
</element-citation>
</ref>
<ref id="R58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van der Auwera</surname>
<given-names>GA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline</article-title>
<source/>Curr. Protoc. Bioinforma. Ed. Board Andreas Baxevanis Al
          <year>2013</year>
<volume>11</volume>
<fpage>11.10.1</fpage>
<lpage>11.10.33</lpage>
</element-citation>
</ref>
<ref id="R59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purcell</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title>
<source/>Am. J. Hum. Genet
          <year>2007</year>
<volume>81</volume>
<fpage>559</fpage>
<lpage>575</lpage>
<pub-id pub-id-type="pmid">17701901</pub-id>
</element-citation>
</ref>
<ref id="R60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>CC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Second-generation PLINK: rising to the challenge of larger and richer datasets</article-title>
<source/>GigaScience
          <year>2015</year>
<volume>4</volume>
<fpage>7</fpage>
<pub-id pub-id-type="pmid">25722852</pub-id>
</element-citation>
</ref>
<ref id="R61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekar</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Schizophrenia risk from complex variation of complement component 4</article-title>
<source/>Nature
          <year>2016</year>
<volume>530</volume>
<fpage>177</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="pmid">26814963</pub-id>
</element-citation>
</ref>
<ref id="R62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cingolani</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3</article-title>
<source/>Fly (Austin)
          <year>2012</year>
<volume>6</volume>
<fpage>80</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="pmid">22728672</pub-id>
</element-citation>
</ref>
<ref id="R63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cingolani</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Using Drosophila melanogaster as a Model for Genotoxic Chemical Mutational Studies with a New Program, SnpSift</article-title>
<source/>Front. Genet
          <year>2012</year>
<volume>3</volume>
<fpage>35</fpage>
<pub-id pub-id-type="pmid">22435069</pub-id>
</element-citation>
</ref>
<ref id="R64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Jian</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Boerwinkle</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>dbNSFP: a lightweight database of human nonsynonymous SNPs and their functional predictions</article-title>
<source/>Hum. Mutat
          <year>2011</year>
<volume>32</volume>
<fpage>894</fpage>
<lpage>899</lpage>
<pub-id pub-id-type="pmid">21520341</pub-id>
</element-citation>
</ref>
<ref id="R65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Jian</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Boerwinkle</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations</article-title>
<source/>Hum. Mutat
          <year>2013</year>
<volume>34</volume>
<fpage>E2393</fpage>
<lpage>2402</lpage>
<pub-id pub-id-type="pmid">23843252</pub-id>
</element-citation>
</ref>
<ref id="R66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsu</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The UCSC Known Genes</article-title>
<source/>Bioinforma. Oxf. Engl
          <year>2006</year>
<volume>22</volume>
<fpage>1036</fpage>
<lpage>1046</lpage>
</element-citation>
</ref>
<ref id="R67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm</article-title>
<source/>Nat. Protoc
          <year>2009</year>
<volume>4</volume>
<fpage>1073</fpage>
<lpage>1081</lpage>
<pub-id pub-id-type="pmid">19561590</pub-id>
</element-citation>
</ref>
<ref id="R68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adzhubei</surname>
<given-names>IA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A method and server for predicting damaging missense mutations</article-title>
<source/>Nat. Methods
          <year>2010</year>
<volume>7</volume>
<fpage>248</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="pmid">20354512</pub-id>
</element-citation>
</ref>
<ref id="R69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chun</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fay</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Identification of deleterious mutations within three human genomes</article-title>
<source/>Genome Res
          <year>2009</year>
<volume>19</volume>
<fpage>1553</fpage>
<lpage>1561</lpage>
<pub-id pub-id-type="pmid">19602639</pub-id>
</element-citation>
</ref>
<ref id="R70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Rödelsperger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schuelke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Seelow</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>MutationTaster evaluates disease-causing potential of sequence alterations</article-title>
<source/>Nat. Methods
          <year>2010</year>
<volume>7</volume>
<fpage>575</fpage>
<lpage>576</lpage>
<pub-id pub-id-type="pmid">20676075</pub-id>
</element-citation>
</ref>
<ref id="R71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reva</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Antipin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sander</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Predicting the functional impact of protein mutations: application to cancer genomics</article-title>
<source/>Nucleic Acids Res
          <year>2011</year>
<volume>39</volume>
<fpage>e118</fpage>
<pub-id pub-id-type="pmid">21727090</pub-id>
</element-citation>
</ref>
<ref id="R72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>AP</given-names>
</name>
</person-group>
<article-title>Predicting the functional effect of amino acid substitutions and indels</article-title>
<source/>PloS One
          <year>2012</year>
<volume>7</volume>
<fpage>e46688</fpage>
<pub-id pub-id-type="pmid">23056405</pub-id>
</element-citation>
</ref>
<ref id="R73">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berman</surname>
<given-names>HM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Protein Data Bank</article-title>
<source/>Nucleic Acids Res
          <year>2000</year>
<volume>28</volume>
<fpage>235</fpage>
<lpage>242</lpage>
<pub-id pub-id-type="pmid">10592235</pub-id>
</element-citation>
</ref>
<ref id="R74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shihab</surname>
<given-names>HA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models</article-title>
<source/>Hum. Mutat
          <year>2013</year>
<volume>34</volume>
<fpage>57</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">23033316</pub-id>
</element-citation>
</ref>
<ref id="R75">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>1000 Genomes Project Consortium</collab>
<etal></etal>
</person-group>
<article-title>An integrated map of genetic variation from 1,092 human genomes</article-title>
<source/>Nature
          <year>2012</year>
<volume>491</volume>
<fpage>56</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">23128226</pub-id>
</element-citation>
</ref>
<ref id="R76">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Goddard</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Visscher</surname>
<given-names>PM</given-names>
</name>
</person-group>
<article-title>GCTA: a tool for genome-wide complex trait analysis</article-title>
<source/>Am. J. Hum. Genet
          <year>2011</year>
<volume>88</volume>
<fpage>76</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="pmid">21167468</pub-id>
</element-citation>
</ref>
<ref id="R77">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Autism Genome Project Consortium</collab>
<etal></etal>
</person-group>
<article-title>Mapping autism risk loci using genetic linkage and chromosomal rearrangements</article-title>
<source/>Nat. Genet
          <year>2007</year>
<volume>39</volume>
<fpage>319</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="pmid">17322880</pub-id>
</element-citation>
</ref>
<ref id="R78">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sebat</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Strong association of de novo copy number mutations with autism</article-title>
<source/>Science
          <year>2007</year>
<volume>316</volume>
<fpage>445</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="pmid">17363630</pub-id>
</element-citation>
</ref>
<ref id="R79">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structural variation of chromosomes in autism spectrum disorder</article-title>
<source/>Am. J. Hum. Genet
          <year>2008</year>
<volume>82</volume>
<fpage>477</fpage>
<lpage>488</lpage>
<pub-id pub-id-type="pmid">18252227</pub-id>
</element-citation>
</ref>
<ref id="R80">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional impact of global rare copy number variation in autism spectrum disorders</article-title>
<source/>Nature
          <year>2010</year>
<volume>466</volume>
<fpage>368</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="pmid">20531469</pub-id>
</element-citation>
</ref>
<ref id="R81">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Itsara</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo rates and selection of large copy number variation</article-title>
<source/>Genome Res
          <year>2010</year>
<volume>20</volume>
<fpage>1469</fpage>
<lpage>1481</lpage>
<pub-id pub-id-type="pmid">20841430</pub-id>
</element-citation>
</ref>
<ref id="R82">
<label>82</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism</article-title>
<source/>Neuron
          <year>2011</year>
<volume>70</volume>
<fpage>863</fpage>
<lpage>885</lpage>
<pub-id pub-id-type="pmid">21658581</pub-id>
</element-citation>
</ref>
<ref id="R83">
<label>83</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levy</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare de novo and transmitted copy-number variation in autistic spectrum disorders</article-title>
<source/>Neuron
          <year>2011</year>
<volume>70</volume>
<fpage>886</fpage>
<lpage>897</lpage>
<pub-id pub-id-type="pmid">21658582</pub-id>
</element-citation>
</ref>
<ref id="R84">
<label>84</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilman</surname>
<given-names>SR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses</article-title>
<source/>Neuron
          <year>2011</year>
<volume>70</volume>
<fpage>898</fpage>
<lpage>907</lpage>
<pub-id pub-id-type="pmid">21658583</pub-id>
</element-citation>
</ref>
<ref id="R85">
<label>85</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Strong association of de novo copy number mutations with sporadic schizophrenia</article-title>
<source/>Nat. Genet
          <year>2008</year>
<volume>40</volume>
<fpage>880</fpage>
<lpage>885</lpage>
<pub-id pub-id-type="pmid">18511947</pub-id>
</element-citation>
</ref>
<ref id="R86">
<label>86</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malhotra</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High frequencies of de novo CNVs in bipolar disorder and schizophrenia</article-title>
<source/>Neuron
          <year>2011</year>
<volume>72</volume>
<fpage>951</fpage>
<lpage>963</lpage>
<pub-id pub-id-type="pmid">22196331</pub-id>
</element-citation>
</ref>
<ref id="R87">
<label>87</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noor</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes</article-title>
<source/>Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet
          <year>2014</year>
<volume>165B</volume>
<fpage>303</fpage>
<lpage>313</lpage>
</element-citation>
</ref>
<ref id="R88">
<label>88</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Georgieva</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo CNVs in bipolar affective disorder and schizophrenia</article-title>
<source/>Hum. Mol. Genet
          <year>2014</year>
<volume>23</volume>
<fpage>6677</fpage>
<lpage>6683</lpage>
<pub-id pub-id-type="pmid">25055870</pub-id>
</element-citation>
</ref>
<ref id="R89">
<label>89</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neale</surname>
<given-names>BM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Patterns and rates of exonic de novo mutations in autism spectrum disorders</article-title>
<source/>Nature
          <year>2012</year>
<volume>485</volume>
<fpage>242</fpage>
<lpage>245</lpage>
<pub-id pub-id-type="pmid">22495311</pub-id>
</element-citation>
</ref>
<ref id="R90">
<label>90</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing</article-title>
<source/>Am. J. Hum. Genet
          <year>2013</year>
<volume>93</volume>
<fpage>249</fpage>
<lpage>263</lpage>
<pub-id pub-id-type="pmid">23849776</pub-id>
</element-citation>
</ref>
<ref id="R91">
<label>91</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Epi4K Consortium</collab>
<etal></etal>
</person-group>
<article-title>De novo mutations in epileptic encephalopathies</article-title>
<source/>Nature
          <year>2013</year>
<volume>501</volume>
<fpage>217</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="pmid">23934111</pub-id>
</element-citation>
</ref>
<ref id="R92">
<label>92</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>EuroEPINOMICS-RES Consortium</collab>
<collab>Epilepsy Phenome/Genome Project</collab>
<collab>Epi4K Consortium</collab>
</person-group>
<article-title>De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies</article-title>
<source/>Am. J. Hum. Genet
          <year>2014</year>
<volume>95</volume>
<fpage>360</fpage>
<lpage>370</lpage>
<pub-id pub-id-type="pmid">25262651</pub-id>
</element-citation>
</ref>
<ref id="R93">
<label>93</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaidi</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in histone-modifying genes in congenital heart disease</article-title>
<source/>Nature
          <year>2013</year>
<volume>498</volume>
<fpage>220</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="pmid">23665959</pub-id>
</element-citation>
</ref>
<ref id="R94">
<label>94</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Ligt</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diagnostic exome sequencing in persons with severe intellectual disability</article-title>
<source/>N. Engl. J. Med
          <year>2012</year>
<volume>367</volume>
<fpage>1921</fpage>
<lpage>1929</lpage>
<pub-id pub-id-type="pmid">23033978</pub-id>
</element-citation>
</ref>
<ref id="R95">
<label>95</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rauch</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study</article-title>
<source/>Lancet
          <year>2012</year>
<volume>380</volume>
<fpage>1674</fpage>
<lpage>1682</lpage>
<pub-id pub-id-type="pmid">23020937</pub-id>
</element-citation>
</ref>
<ref id="R96">
<label>96</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilissen</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome sequencing identifies major causes of severe intellectual disability</article-title>
<source/>Nature
          <year>2014</year>
<volume>511</volume>
<fpage>344</fpage>
<lpage>347</lpage>
<pub-id pub-id-type="pmid">24896178</pub-id>
</element-citation>
</ref>
<ref id="R97">
<label>97</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamdan</surname>
<given-names>FF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in moderate or severe intellectual disability</article-title>
<source/>PLoS Genet
          <year>2014</year>
<volume>10</volume>
<fpage>e1004772</fpage>
<pub-id pub-id-type="pmid">25356899</pub-id>
</element-citation>
</ref>
<ref id="R98">
<label>98</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girard</surname>
<given-names>SL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased exonic de novo mutation rate in individuals with schizophrenia</article-title>
<source/>Nat. Genet
          <year>2011</year>
<volume>43</volume>
<fpage>860</fpage>
<lpage>863</lpage>
<pub-id pub-id-type="pmid">21743468</pub-id>
</element-citation>
</ref>
<ref id="R99">
<label>99</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gulsuner</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network</article-title>
<source/>Cell
          <year>2013</year>
<volume>154</volume>
<fpage>518</fpage>
<lpage>529</lpage>
<pub-id pub-id-type="pmid">23911319</pub-id>
</element-citation>
</ref>
<ref id="R100">
<label>100</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCarthy</surname>
<given-names>SE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability</article-title>
<source/>Mol. Psychiatry
          <year>2014</year>
<volume>19</volume>
<fpage>652</fpage>
<lpage>658</lpage>
<pub-id pub-id-type="pmid">24776741</pub-id>
</element-citation>
</ref>
<ref id="R101">
<label>101</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamosh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Amberger</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Bocchini</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>McKusick</surname>
<given-names>VA</given-names>
</name>
</person-group>
<article-title>Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders</article-title>
<source/>Nucleic Acids Res
          <year>2005</year>
<volume>33</volume>
<fpage>D514</fpage>
<lpage>517</lpage>
<pub-id pub-id-type="pmid">15608251</pub-id>
</element-citation>
</ref>
<ref id="R102">
<label>102</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Stevenson</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>RC</given-names>
</name>
</person-group>
<source/>Atlas of X-linked intellectual disability syndromes
          <year>2012</year>
<publisher-name>Oxford University Press</publisher-name>
</element-citation>
</ref>
<ref id="R103">
<label>103</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moeschler</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Shevell</surname>
<given-names>M</given-names>
</name>
<collab>American Academy of Pediatrics Committee on Genetics</collab>
</person-group>
<article-title>Clinical genetic evaluation of the child with mental retardation or developmental delays</article-title>
<source/>Pediatrics
          <year>2006</year>
<volume>117</volume>
<fpage>2304</fpage>
<lpage>2316</lpage>
<pub-id pub-id-type="pmid">16740881</pub-id>
</element-citation>
</ref>
<ref id="R104">
<label>104</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rauch</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation</article-title>
<source/>Am. J. Med. Genet. A
          <year>2006</year>
<volume>140</volume>
<fpage>2063</fpage>
<lpage>2074</lpage>
<pub-id pub-id-type="pmid">16917849</pub-id>
</element-citation>
</ref>
<ref id="R105">
<label>105</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cotton</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of expressed SNPs identifies variable extents of expression from the human inactive X chromosome</article-title>
<source/>Genome Biol
          <year>2013</year>
<volume>14</volume>
<fpage>R122</fpage>
<pub-id pub-id-type="pmid">24176135</pub-id>
</element-citation>
</ref>
<ref id="R106">
<label>106</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crow</surname>
<given-names>TJ</given-names>
</name>
</person-group>
<article-title>The XY gene hypothesis of psychosis: origins and current status</article-title>
<source/>Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet
          <year>2013</year>
<volume>162B</volume>
<fpage>800</fpage>
<lpage>824</lpage>
</element-citation>
</ref>
<ref id="R107">
<label>107</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Higa</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Kelsoe</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Over-expression of XIST, the Master Gene for X Chromosome Inactivation, in Females With Major Affective Disorders</article-title>
<source/>EBioMedicine
          <year>2015</year>
<volume>2</volume>
<fpage>907</fpage>
<lpage>916</lpage>
</element-citation>
</ref>
<ref id="R108">
<label>108</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crow</surname>
<given-names>TJ</given-names>
</name>
</person-group>
<article-title>Is Psychosis a Disorder of XY Epigenetics?</article-title>
<source/>EBioMedicine
          <year>2015</year>
<volume>2</volume>
<fpage>792</fpage>
<lpage>793</lpage>
<pub-id pub-id-type="pmid">26425679</pub-id>
</element-citation>
</ref>
<ref id="R109">
<label>109</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vilhjálmsson</surname>
<given-names>BJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores</article-title>
<source/>Am. J. Hum. Genet
          <year>2015</year>
<volume>97</volume>
<fpage>576</fpage>
<lpage>592</lpage>
<pub-id pub-id-type="pmid">26430803</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<title>Ultra-rare variants distribution and association with schizophrenia</title>
<p>(<bold>a-b</bold>) Counts across coding-sequence and splice-site rare variants stratified by minor allele count across exome sequencing data from 12,332 individuals indicating (<bold>a</bold>) how many variants were observed in the ExAC cohort and (<bold>b</bold>) how many variants were classified as disruptive, damaging, missense non-damaging, and synonymous. (<bold>c</bold>) Observed enrichment in schizophrenia cases compared to controls for coding-sequence and splice-site URVs across the main four annotation types. Enrichment and <italic>P</italic> values were computed using a linear regression model (left panel) and a logistic regression model (right panel). Horizontal bars indicate 95% confidence intervals.</p>
</caption>
<graphic xlink:href="nihms-815183-f0001"></graphic>
</fig>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<title>dURVs enrichement in schizophrenia cases across selected gene sets</title>
<p>Excess per case and odds ratios for dURVs across loss-of-function intolerant (LoF-intolerant) genes, missense constrained genes, protein complexes genes, genes associated through common variants, predicted microRNA-137 targets, and intellectual disability genes. Enrichment and <italic>P</italic> values were computed using a linear regression model (left panel) and a logistic regression model (right panel) using exome-wide dURV count as a covariate to correct for average exome-wide burden (dot-dashed line). Horizontal bars indicate 95% confidence intervals.</p>
</caption>
<graphic xlink:href="nihms-815183-f0002"></graphic>
</fig>
<fig id="F3" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<title>dURVs enrichment in schizophrenia cases across tissue, brain cell type, and synaptic gene sets</title>
<p>Excess per case and odds ratios for dURVs across genes with higher expression in a given tissue (<bold>a</bold>), genes with higher expression in a given cell type (<bold>b</bold>), and genes expected to localize to synapses (<bold>c</bold>). Enrichment and <italic>P</italic> values were computed using a linear regression model (left panels) and a logistic regression model (right panels) using exome-wide dURV count as a covariate to correct for average exome-wide burden (dot-dashed line). Horizontal bars indicate 95% confidence intervals.</p>
</caption>
<graphic xlink:href="nihms-815183-f0003"></graphic>
</fig>
<fig id="F4" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<title>dURVs enrichment in schizophrenia cases across brain cell type gene sets stratified by synaptic localization</title>
<p>Odds ratios for enrichment of dURVs across genes expressed in brain tissue, neuronal cells, inhibitory neurons, and excitatory neurons, stratified between genes recognized as synaptic and genes recognized as non-synaptic. Synaptic genes were defined as genes part of either the FMRP, <italic>RBFOX2</italic>, <italic>CELF4</italic>, or SynaptomeDB gene sets. Enrichment and <italic>P</italic> values were computed using a logistic regression model using exome-wide dURV count as a covariate to correct for average exome-wide burden (dot-dashed line). Horizontal bars indicate 95% confidence intervals. Across each gene set, synaptic genes are clearly more enriched for variants in schizophrenia cases than non-synaptic genes.</p>
</caption>
<graphic xlink:href="nihms-815183-f0004"></graphic>
</fig>
<fig id="F5" orientation="portrait" position="float">
<label>Figure 5</label>
<caption>
<title>dURVs enrichment in schizophrenia cases across genes previously observed as affected by <italic>de novo</italic> mutations</title>
<p>Odds ratios for enrichment of dURVs across (<bold>a</bold>) genes overlapping <italic>de novo</italic> deletions and duplications in schizophrenia, bipolar disorder, and autism trios, and across (<bold>b</bold>) loss-of-function intolerant (LoF-intolerant) genes with observed <italic>de novo</italic> mutations in schizophrenia, intellectual disability, congenital heart disease, epilepsy, and autism trios. Enrichment and <italic>P</italic> values were computed using a logistic regression model using exome-wide dURV count (<bold>a</bold>) and dURV count across LoF-intolerant genes (<bold>b</bold>) as a covariate to correct for average burden (dot-dashed line). Horizontal bars indicate 95% confidence intervals.</p>
</caption>
<graphic xlink:href="nihms-815183-f0005"></graphic>
</fig>
<fig id="F6" orientation="portrait" position="float">
<label>Figure 6</label>
<caption>
<title>Dissection of the dURVs enrichment in schizophrenia cases</title>
<p>An enrichment of URVs in the exomes of individuals affected with schizophrenia (relative to variants in control exomes) is observed exclusively in dURVs. After correcting for exome-wide dURV count, this enrichment is observed as concentrated in brain-specific genes while not in other tissue-specific genes, in neuron-specific genes while not in other brain-cell type-specific genes, and finally in potentially synaptic genes while not in other neuronally expressed genes.</p>
</caption>
<graphic xlink:href="nihms-815183-f0006"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>